Hussain R, Rehman W, Khan S, Jaber F, Rahim F, Shah M
Saudi Pharm J. 2023; 31(11):101823.
PMID: 37965293
PMC: 10641276.
DOI: 10.1016/j.jsps.2023.101823.
Benfatto S, Sercin O, Dejure F, Abdollahi A, Zenke F, Mardin B
Mol Cancer. 2021; 20(1):111.
PMID: 34454516
PMC: 8401190.
DOI: 10.1186/s12943-021-01405-8.
Almandil N, Taha M, Farooq R, Alhibshi A, Ibrahim M, Anouar E
Molecules. 2019; 24(6).
PMID: 30871147
PMC: 6471342.
DOI: 10.3390/molecules24061002.
Oh T, El Kouni M
PLoS One. 2018; 13(8):e0202826.
PMID: 30138393
PMC: 6107277.
DOI: 10.1371/journal.pone.0202826.
Zhang Q, Zhang Y, Hu X, Qin Y, Zhong W, Meng J
Lab Invest. 2017; 97(8):903-912.
PMID: 28530649
DOI: 10.1038/labinvest.2017.51.
Thymidine Phosphorylase in Cancer; Enemy or Friend?.
Elamin Y, Rafee S, Osman N, O Byrne K, Gately K
Cancer Microenviron. 2015; 9(1):33-43.
PMID: 26298314
PMC: 4842186.
DOI: 10.1007/s12307-015-0173-y.
Kinetic mechanism of Toxoplasma gondii adenosine kinase and the highly efficient utilization of adenosine.
Naguib F, Rais R, Al Safarjalani O, El Kouni M
Comp Biochem Physiol B Biochem Mol Biol. 2015; 188:63-9.
PMID: 26112826
PMC: 4530035.
DOI: 10.1016/j.cbpb.2015.06.006.
Thymidine phosphorylase activates NFκB and stimulates the expression of angiogenic and metastatic factors in human cancer cells.
Tabata S, Ikeda R, Yamamoto M, Shimaoka S, Mukaida N, Takeda Y
Oncotarget. 2014; 5(21):10473-85.
PMID: 25350954
PMC: 4279387.
DOI: 10.18632/oncotarget.2242.
Relationship between the expression of thymidylate synthase, thymidine phosphorylase and dihydropyrimidine dehydrogenase and survival in epithelial ovarian cancer.
Wang C, Weng Y, Wang H, Shi Y, Ma D
J Huazhong Univ Sci Technolog Med Sci. 2010; 30(4):494-9.
PMID: 20714877
DOI: 10.1007/s11596-010-0456-y.
The dual role of thymidine phosphorylase in cancer development and chemotherapy.
Bronckaers A, Gago F, Balzarini J, Liekens S
Med Res Rev. 2009; 29(6):903-53.
PMID: 19434693
PMC: 7168469.
DOI: 10.1002/med.20159.
The cytosol activity of thymidine phosphorylase in endometrial cancer.
Miszczak-Zaborska E, Kubiak R, Bienkiewicz A, Bartkowiak J
J Exp Clin Cancer Res. 2008; 27:64.
PMID: 18986516
PMC: 2588563.
DOI: 10.1186/1756-9966-27-64.
The role of DNA synthesis imaging in cancer in the era of targeted therapeutics.
Nimmagadda S, Shields A
Cancer Metastasis Rev. 2008; 27(4):575-87.
PMID: 18512023
PMC: 3086165.
DOI: 10.1007/s10555-008-9148-5.
Structural basis for non-competitive product inhibition in human thymidine phosphorylase: implications for drug design.
El Omari K, Bronckaers A, Liekens S, Perez-Perez M, Balzarini J, Stammers D
Biochem J. 2006; 399(2):199-204.
PMID: 16803458
PMC: 1609907.
DOI: 10.1042/BJ20060513.
Interferons upregulate thymidine phosphorylase expression via JAK-STAT-dependent transcriptional activation and mRNA stabilization in human glioblastoma cells.
Yao Y, Kubota T, Sato K, Takeuchi H, Kitai R, Matsukawa S
J Neurooncol. 2005; 72(3):217-23.
PMID: 15937643
DOI: 10.1007/s11060-004-3012-4.
The role of thymidine phosphorylase, an angiogenic enzyme, in tumor progression.
Akiyama S, Furukawa T, Sumizawa T, Takebayashi Y, Nakajima Y, Shimaoka S
Cancer Sci. 2004; 95(11):851-7.
PMID: 15546501
PMC: 11159696.
DOI: 10.1111/j.1349-7006.2004.tb02193.x.
Dihydropyrimidine dehydrogenase in normal and malignant endometrium: relationship with cell proliferation and thymidine phosphorylase.
Fujiwaki R, Iida K, Nakayama K, Kanasaki H, Ozaki T, Hata K
Virchows Arch. 2003; 443(5):672-7.
PMID: 12910418
DOI: 10.1007/s00428-003-0866-3.
Expression of thymidine phosphorylase in primary human renal cell carcinoma by ELISA method.
Kinsui H, Ueda T, Suzuki H, Isaka S, Sekita N, Komiya A
Jpn J Cancer Res. 2002; 93(3):340-5.
PMID: 11927017
PMC: 5926977.
DOI: 10.1111/j.1349-7006.2002.tb02177.x.
Structural analyses reveal two distinct families of nucleoside phosphorylases.
Pugmire M, Ealick S
Biochem J. 2001; 361(Pt 1):1-25.
PMID: 11743878
PMC: 1222293.
DOI: 10.1042/0264-6021:3610001.
Thymidine phosphorylase, 2-deoxy-D-ribose and angiogenesis.
Brown N, Bicknell R
Biochem J. 1998; 334 ( Pt 1):1-8.
PMID: 9693094
PMC: 1219653.
DOI: 10.1042/bj3340001.
Platelet-derived endothelial cell growth factor thymidine phosphorylase in tumour growth and response to therapy.
Griffiths L, Stratford I
Br J Cancer. 1997; 76(6):689-93.
PMID: 9310231
PMC: 2228052.
DOI: 10.1038/bjc.1997.447.